Advertisement

POZ June 2019

POZ June 2019

In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.

Also Available On:

ISSUU

Features

Danez Smith

The Power of Storytelling

Exploring intersectionality through poetry

Self Care Activism illustration

What Price Activism?

Coping with the fight for change

Editor’s Letter

Oriol R. Gutierrez

True Colors

Exploring LGBT and HIV intersectionality is the theme of this special issue.

POZ Q+A

Laura Linney and Olympia Dukakis  Tales of the City

Tales for Everyone

Author Armistead Maupin also shares insights about married life, bathhouses and his scandalous relationship with Rock Hudson.

POZ Planet

Busting HIV Stigma Through Stories

“And So It Happened” profiles people taking HIV treatment and PrEP.

Visual artist Kaz Senju documents Tokyo’s gay bar scene through photos and interviews.

Books for Pride

LGBT and HIV themes abound in these latest offerings.

Advocates rally at the White House

AIDSWatch 2019

At this year’s AIDSWatch, activists called out CDC director Robert Redfield for the health agency’s patent rights on Truvada for PrEP.

POZ June/July 1994

POZ at 25 — June

A look at June issues from the POZ archives

Everyday

Everyday — June 2019

Here are some important dates in AIDS history.

Voices

Prevention Access Campaign U=U

What Works?

Long-term survivor Bob Leahy talks about what HIV looks like in 2019 versus 1989.

Spotlight

#UequalsU

A social media recap of our March 2019 issue on U=U.

Care And Treatment

Stem Cell Research Pipette

New Cases of HIV Cure?

A second man’s virus went into remission following an HIV-resistant stem cell transplant to treat his cancer.

June 2019 desk calendar

Monthly Injectable Treatment

Given every four weeks, the combo injection of cabotegravir and Edurant (rilpivirine) will likely face an FDA decision by early 2020.

human liver cancer cells

Liver Cancer Risk

HIV-positive people with a higher viral load over a longer period appear more likely to develop hepatocellular carcinoma.

Statue of Liberty, New York City

High Hep C Reinfection Rate

Gay and bisexual men with HIV who are cured of hep C are reinfected at a high rate.

Research Notes

Prevention: Descovy PrEP

Truvada and Descovy are both highly effective and generally safe options for HIV prevention.

Treatment: 3-Month Dosing

An early trial of Gilead’s HIV capsid inhibitor supports three-month dosing.

DNA Sequencing Gel

Cure: Reservoir Test

A new, more accurate HIV reservoir test is a big advance for cure research.

Concerns: Cardiac Death

According to a systematic review and meta-analysis of dozens of studies, people with HIV have high rates of cardiac dysfunction

Heroes

Dee Dee Chamblee

Champion of Change

Dee Dee Chamblee is a transgender activist in Atlanta.

Survey

woman sunrise mountains illustration

Quality of Life

Digital Edition

POZ June 2019 cover

POZ June 2019

Read the digital edition!

Advertisement

Hot topics